| Christine Benitez, MCD, CCC-SLP | |
|
2450 Village Professional Dr N, Opelika, AL 36801-4734 | |
| (334) 528-1964 | |
| (334) 742-9352 |
| Full Name | Christine Benitez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2450 Village Professional Dr N, Opelika, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548648090 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3683 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Benitez, MCD, CCC-SLP 2450 Village Professional Dr N, Opelika, AL 36801-4734 Ph: (334) 528-1964 | Christine Benitez, MCD, CCC-SLP 2450 Village Professional Dr N, Opelika, AL 36801-4734 Ph: (334) 528-1964 |
News Archive
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis.
Omeros Corporation (Nasdaq: OMER) today announced that it has obtained an exclusive license from The Regents of the University of California to a new series of antifibrinolytic agents. These optimized agents represent a significant potential advance in the control of surgical and traumatic bleeding.
According to a study in the May/June 2007 issue of the journal Ground Water, pharmaceuticals are being found in septic tanks and, consequentially, ground water due to incomplete human metabolism and excretion into the waste stream or by disposal of unused medications in the toilet or down the sink.
Elan Drug Technologies, the drug delivery unit of Elan Corporation, plc, today announced that the first injectable product using EDT's NanoCrystal technology has been approved by the European Commission.
› Verified 7 days ago
Calm Connection, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2109 Austell St, Opelika, AL 36801 Phone: 334-444-3610 | |
Ashley Spurlin, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2450 Village Professional Dr N, Opelika, AL 36801 Phone: 334-528-1964 | |
Leigh Sayers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1387 | |
Ashley Farmer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 704 Avenue D, Opelika, AL 36801 Phone: 334-750-5454 | |
Mrs. Emily Sanderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 403 2nd Ave, Suite 101, Opelika, AL 36801 Phone: 334-741-4041 | |
Mrs. Linda P Rubio, MSC, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2101 Executive Park Dr, Opelika, AL 36801 Phone: 334-749-0146 |